Quantification of bone marrow disease in high risk neuroblastoma patients with anti-GD2 immunocytochemistry at diagnosis and at end of induction therapy - Impact on event-free and overall survival. A siopen high risk study

---

Autoria(s): Beiske Klaus; Sementa Angela; Jeison Marta; Vicha Ales; Klijanienko Jerzy; Papadakis Vassilios; Yanez Yania; Wieczorek Aleksandra; Boubaker Ariane; Cvancarova Milada; Poetschger Ulrike; Ladenstein Ruth; Swerts Katrien

Data(s)	2012
Identificador	http://serval.unil.ch/?id=serval:BIB_54469886EACD isbn:1545-5009 isiid:000309754300119
Idioma(s)	en
Fonte	44th Congress of the International Society of Paediatric Oncology (SIOP) 2012
Tipo	info:eu-repo/semantics/conferenceObject inproceedings